|
Related Party Transactions - Additional Information (Detail) (USD $)
|
0 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 6 Months Ended | 6 Months Ended | 0 Months Ended | 3 Months Ended | 6 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | 0 Months Ended | 6 Months Ended | 0 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 15, 2010
|
Mar. 31, 2014
extension
|
Jun. 30, 2014
|
Dec. 31, 2013
|
Oct. 31, 2013
|
Apr. 10, 2013
|
Jun. 30, 2014
Financial Guarantee [Member]
|
Mar. 31, 2014
Financial Guarantee [Member]
|
Jun. 30, 2014
John Pappajohn [Member]
|
Jun. 30, 2014
John Pappajohn [Member]
Financial Guarantee [Member]
|
Mar. 31, 2014
John Pappajohn [Member]
Financial Guarantee [Member]
|
Jun. 30, 2014
John Pappajohn [Member]
IPO [Member]
|
Jun. 30, 2014
Chairman of the Board [Member]
|
Jan. 03, 2014
Chairman of the Board [Member]
2011 Equity Plan [Member]
|
Apr. 10, 2013
Dr. Chaganti [Member]
|
Jun. 30, 2014
Dr. Chaganti [Member]
patent
|
Jun. 30, 2013
Dr. Chaganti [Member]
|
Apr. 10, 2013
Dr. Chaganti [Member]
|
Jun. 30, 2014
Dr. Chaganti [Member]
patent
|
Jun. 30, 2014
Dr. Chaganti [Member]
2011 Equity Plan [Member]
|
Aug. 31, 2010
Equity Dynamics, Inc. [Member]
|
Jun. 30, 2014
Equity Dynamics, Inc. [Member]
|
Jun. 30, 2013
Equity Dynamics, Inc. [Member]
|
Jun. 30, 2014
Equity Dynamics, Inc. [Member]
|
Jun. 30, 2013
Equity Dynamics, Inc. [Member]
|
Jan. 03, 2014
Compensation for Serving as Chairman of Board [Member]
Chairman of the Board [Member]
|
Jun. 30, 2014
Compensation for Serving as Chairman of Board [Member]
Chairman of the Board [Member]
installment
|
Jun. 30, 2014
Consulting and Advisory Agreement [Member]
|
Jun. 30, 2013
Consulting and Advisory Agreement [Member]
|
Jan. 03, 2014
Restricted Stock [Member]
Chairman of the Board [Member]
|
|
| Related Party Transaction [Line Items] | ||||||||||||||||||||||||||||||
| Number of revolving line of credit extensions facility | 8 | |||||||||||||||||||||||||||||
| Common stock purchased | 284,000 | 202,630 | 1,051,506 | |||||||||||||||||||||||||||
| Common stock exercised (in shares) | 60,203 | 440,113 | ||||||||||||||||||||||||||||
| Warrants adjusted in conjunction with IPO | 436,079 | 585,645 | ||||||||||||||||||||||||||||
| Warrants outstanding per share | $ 15 | $ 15 | ||||||||||||||||||||||||||||
| Additional amount of loan received | $ 6,750,000 | |||||||||||||||||||||||||||||
| Convertible shares issued to common stock | 9,464,709 | 9,275,384 | 10,000 | 690,000 | 675,000 | |||||||||||||||||||||||||
| Conversion price of notes | $ 10 | |||||||||||||||||||||||||||||
| Agreement with related party, description of required payment | As compensation for serving as the Chairman of the Board, the Company will pay Mr. Pappajohn $100,000 per year and granted to Mr. Pappajohn 25,000 restricted shares of the Company's common stock, and options to purchase an aggregate of 100,000 shares of the Company's common stock. | In exchange for this assignment, if the USPTO issues a patent for an invention on which Dr. Chaganti is listed as an inventor, we are required to pay Dr. Chaganti (i) a one-time payment of $50,000 and (ii) 1% of any net revenues we receive from any licensed sales of the invention. | ||||||||||||||||||||||||||||
| Compensation for serving as chairman of the board | 100,000 | |||||||||||||||||||||||||||||
| Restricted shares issued | 25,000 | |||||||||||||||||||||||||||||
| Shares granted | 465,000 | 426,762 | 100,000 | 200,000 | ||||||||||||||||||||||||||
| Effective appointment date | Jan. 06, 2014 | |||||||||||||||||||||||||||||
| Options granted period | 10 years | |||||||||||||||||||||||||||||
| Number of installments | 2 | |||||||||||||||||||||||||||||
| Options term and vesting period description | The options have a term of ten years from the date on which they were granted. The restricted stock and the options each vest in two equal installments on the one year anniversary and the two year anniversary of the date on which Mr. Pappajohn became the Chairman of the Board. | |||||||||||||||||||||||||||||
| Notes issued to related party | 100,000 | |||||||||||||||||||||||||||||
| Interest rate due to related party | 8.50% | |||||||||||||||||||||||||||||
| Interest expenses on notes issued to related party | 2,400 | |||||||||||||||||||||||||||||
| Convertible common shares | 13,430 | |||||||||||||||||||||||||||||
| Common stock conversion price, per share | $ 10.00 | |||||||||||||||||||||||||||||
| Stock options issued to purchase shares of common stock | 36,000 | |||||||||||||||||||||||||||||
| Common stock price per share | $ 10 | |||||||||||||||||||||||||||||
| Common stock, vesting period | 2 years | |||||||||||||||||||||||||||||
| Consulting and advisory agreement expenses under stock option plan | 0 | 54,650 | ||||||||||||||||||||||||||||
| Consulting agreement period | 3 years | |||||||||||||||||||||||||||||
| Consulting and advisory services fee | 5,000 | |||||||||||||||||||||||||||||
| Agreement with related party, consulting fee | 15,000 | 15,000 | 0 | 30,000 | 30,000 | 60,000 | ||||||||||||||||||||||||
| Common stock, shares purchased price per share | $ 15.89 | |||||||||||||||||||||||||||||
| Agreement with related party, one-time payment required | 50,000 | |||||||||||||||||||||||||||||
| Agreement with related party, percentage of net revenues required to be paid | 1.00% | |||||||||||||||||||||||||||||
| Patents expense paid | 150,000 | |||||||||||||||||||||||||||||
| Number of patents were issued | 3 | 3 | ||||||||||||||||||||||||||||
| Agreement with related party, fee | 10,000 | |||||||||||||||||||||||||||||
| Due to related party | $ 0 | $ 0 | ||||||||||||||||||||||||||||